{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:02:06Z","timestamp":1784786526759,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011491","name":"Bureau of Science and Technology of Zhoushan","doi-asserted-by":"publisher","award":["2017C31125, 2018C31118, 2017B02"],"award-info":[{"award-number":["2017C31125, 2018C31118, 2017B02"]}],"id":[{"id":"10.13039\/501100011491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Coxsackie virus group A type 16 (CoxA16) is the main pathogen and usually an alternative to or joins in prevalence with enterovirus 71 (EV71) causing hand, foot and mouth disease (HFMD). The\u00a0objective of this study was to estimate the seroprevalence of CoxA16 antibody among people of various age groups by a systematic review and meta-analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The literature of seroprevalence of CoxA16 antibody among people has been systematically searched through databases from the date of their establishment to Jan. 2021. Estimates of seroprevalence of CoxA16 antibody by gender and age groups have been summarized by using fixed- and random- effect models. All analyses have been conducted in STATA version 12.0 software.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 14 publications with 9 in English and 5 in Chinese containing 9562 samples were finally included in the meta-analysis. The seroprevalence of CoxA16 antibody reported in different studies range from 24.85 to 76.92\u2009%. Meta-analysis has revealed that the seroprevalence of CoxA16 antibody was 56.3\u2009% (95\u00a0%CI: 47.7\u2009%~64.9\u2009%) in the overall population and 55.1\u2009% (95\u00a0%CI: 44.1\u2009%~66.1\u2009%) in the Chinese population. Subgroup analysis by gender has revealed that the seroprevalence of CoxA16 antibody was 56.1\u2009% (95\u00a0%CI: 45.2\u2009%~67.1\u2009%) in males and 60.0\u2009% (95\u00a0%CI: 50.0\u2009%~69.9\u2009%) in females. Subgroup analysis by age groups has revealed that the seroprevalence of CoxA16 antibody was 49.1\u2009% (95\u00a0%CI: 36.2\u2009%~62.0\u2009%) in the 0\u2009~\u20095 age group and 63.9\u2009% (95\u00a0%CI: 53.1\u2009%~74.7\u2009%) in the over 5 age group. Begg\u2019s funnel plots have suggested that there were no publication bias in all groups. Sensitive analysis has suggested that the\u00a0result of the meta-analysis was stable.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The seroprevalence of CoxA16 antibody was closely related to age. Children under 5 years old were the main susceptible groups for CoxA16 and also the key groups for the prevention and control of HFMD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13690-021-00688-z","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T04:03:09Z","timestamp":1631851389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Seroprevalence of coxsackievirus A16 antibody among people of various age groups: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2533-1864","authenticated-orcid":false,"given":"Peng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Bo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"issue":"7","key":"688_CR1","first-page":"676","volume":"32","author":"ZR Chang","year":"2011","unstructured":"Chang ZR, Zhang J, Sun JL, Zhang WD, Wang ZJ. Epidemiological features of hand, foot and mouth disease in China, 2008\u20132009. Zhonghua Liu Xing Bing Xue Za Zhi. 2011;32(7):676\u201380.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"9","key":"688_CR2","first-page":"1234","volume":"47","author":"XF Wang","year":"2018","unstructured":"Wang XF, Lu J, Liu XX, Dai T. Epidemiological features of hand, foot and mouth disease outbreaks among Chinese preschool children: a meta-analysis. Iran J Public Health. 2018;47(9):1234\u201343.","journal-title":"Iran J Public Health"},{"issue":"1","key":"688_CR3","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12879-019-3878-6","volume":"19","author":"K Cai","year":"2019","unstructured":"Cai K, Wang Y, Guo Z, Yu H, Li H, Zhang L, Xu S, Zhang Q. Clinical characteristics and managements of severe hand, foot and mouth disease caused by enterovirus A71 and coxsackievirus A16 in Shanghai, China. BMC Infect Dis. 2019;19(1):285. https:\/\/doi.org\/10.1186\/s12879-019-3878-6.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"688_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12879-018-3659-7","volume":"19","author":"H Ji","year":"2019","unstructured":"Ji H, Fan H, Lu PX, Zhang XF, Ai J, Shi C, et al. Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology,etiology, and disease burden. BMC Infect Dis. 2019;19(1):79. https:\/\/doi.org\/10.1186\/s12879-018-3659-7.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"688_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11262-012-0814-x","volume":"46","author":"X Fan","year":"2013","unstructured":"Fan X, Jiang J, Liu Y, Huang X, Wang P, Liu L, Wang J, Chen W, Wu W, Xu B. Detection of human enterovirus 71 and Coxsackievirus A16 in an outbreak of hand, foot, and mouth disease in Henan Province, China in 2009. Virus Genes. 2013;46(1):1\u20139.","journal-title":"Virus Genes"},{"issue":"1","key":"688_CR6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41426-018-0215-x","volume":"7","author":"P Noisumdaeng","year":"2018","unstructured":"Noisumdaeng P, Sangsiriwut K, Prasertsopon J, Klinmalai C, Payungporn S, Mungaomklang A. Complete genome analysis demonstrates multiple introductions of enterovirus 71 and coxsackievirus A16recombinant strains into Thailand during the past decade. Emerg Microbes Infect. 2018;7(1):214\u201320.","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"688_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12929-019-0573-2","volume":"26","author":"J Puenpa","year":"2019","unstructured":"Puenpa J, Wanlapakorn N, Vongpunsawad S, Poovorawan Y. The history of enterovirus A71 outbreaks and molecular epidemiology in the Asia-Pacific Region. J Biomed Sci. 2019;26(1):75. https:\/\/doi.org\/10.1186\/s12929-019-0573-2.","journal-title":"J Biomed Sci"},{"issue":"2","key":"688_CR8","first-page":"189","volume":"33","author":"AP Deng","year":"2012","unstructured":"Deng AP, Zhang YH, Sun LM, Zeng HR, Li W, Ke CW, et al. Survey on the recessive infection of pathogen to hand-foot-mouth disease among healthy adults and children in Guangdong province. Zhonghua Liu Xing Bing Xue Za Zhi. 2012;33(2):189\u201391.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"12","key":"688_CR9","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1097\/INF.0000000000000900","volume":"34","author":"B Yang","year":"2015","unstructured":"Yang B, Wu P, Wu JT, Lau EH, Leung GM, Yu H, Cowling BJ. Seroprevalence of enterovirus 71 antibody among children in china: a systematic review and meta-analysis. Pediatr Infect Dis J. 2015;34(12):1399\u2013406.","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"688_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3109\/00365548.2014.907929","volume":"46","author":"Y Fang","year":"2014","unstructured":"Fang Y, Wang S, Zhang L, Guo Z, Huang Z, Tu C, Zhu BP. Risk factors of severe hand, foot and mouth disease: a meta-analysis. Scand J Infect Dis. 2014;46(7):515\u201322.","journal-title":"Scand J Infect Dis"},{"key":"688_CR11","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","volume":"349","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and metaanalysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647.","journal-title":"BMJ"},{"key":"688_CR12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"688_CR13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1037\/1082-989X.3.4.486","volume":"3","author":"LV Hedges","year":"1998","unstructured":"Hedges LV, Vevea JL. Fixed-and random-effects models in meta-analysis. Psychol Methods. 1998;3:486\u2013504.","journal-title":"Psychol Methods"},{"issue":"6","key":"688_CR14","first-page":"454","volume":"30","author":"C Cheng","year":"2016","unstructured":"Cheng C, Pang HY. Seroepidemiologic investigation of enterovirus CA16 among children in Donghai County. Chin J School Doctor. 2016;30(6):454\u20136.","journal-title":"Chin J School Doctor"},{"issue":"6","key":"688_CR15","first-page":"877","volume":"24","author":"XY Han","year":"2014","unstructured":"Han XY, Pan J, Liu LZ, Yang GL, Guan HY, Wang CR. Serological investigation on hand foot and mouth disease in healthy population in Jinan. Chin J Health Lab. 2014;24(6):877\u20138.","journal-title":"Chin J Health Lab"},{"issue":"9","key":"688_CR16","first-page":"911","volume":"22","author":"QY Mao","year":"2009","unstructured":"Mao QY, Yang ZW, Yu X, et al. Epidemic tendency of neutralizing antibody against Enterovirus 71 and Coxsackievirus A 16 in Infants in Rural Area of Kaifeng City, Henan Province,China. Chin J Biologicals. 2009;22(9):911\u20133.","journal-title":"Chin J Biologicals"},{"issue":"8","key":"688_CR17","first-page":"147","volume":"33","author":"D Song","year":"2020","unstructured":"Song D. Serological survey of hand, foot and mouth disease among healthy people in Hebei District, Tianjin City. 2016 ~ 2019 Medical Information. 2020;33(8):147\u20139.","journal-title":"2016 ~ 2019 Medical Information"},{"issue":"5","key":"688_CR18","doi-asserted-by":"publisher","first-page":"e0127999","DOI":"10.1371\/journal.pone.0127999","volume":"10","author":"LW Ang","year":"2015","unstructured":"Ang LW, Tay J, Phoon MC, Hsu JP, Cutter J, James L, Goh KT, Chow VT. Seroepidemiology of Coxsackievirus A6, Coxsackievirus A16, and Enterovirus 71 infections among children and adolescents in Singapore, 2008\u20132010. PLoS One. 2015;10(5):e0127999.","journal-title":"PLoS One"},{"issue":"5","key":"688_CR19","doi-asserted-by":"publisher","first-page":"e37206","DOI":"10.1371\/journal.pone.0037206","volume":"7","author":"FC Zhu","year":"2012","unstructured":"Zhu FC, Liang ZL, Meng FY, Zeng Y, Mao QY, Chu K, et al. Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants. PLoS One. 2012;7(5):e37206.","journal-title":"PLoS One"},{"issue":"1","key":"688_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12985-018-1074-8","volume":"15","author":"H Lerdsamran","year":"2018","unstructured":"Lerdsamran H, Prasertsopon J, Mungaomklang A, Klinmalai C, Noisumdaeng P, Sangsiriwut K, Tassaneetrithep B, Guntapong R, et al. Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand. Virol J. 2018;15(1):158\u201362.","journal-title":"Virol J"},{"issue":"1","key":"688_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00430-009-0133-6","volume":"199","author":"HF Rabenau","year":"2010","unstructured":"Rabenau HF, Richter M, Doerr HW. Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Med Microbiol Immunol. 2010;199(1):45\u201351.","journal-title":"Med Microbiol Immunol"},{"issue":"9","key":"688_CR22","doi-asserted-by":"publisher","first-page":"e0162373","DOI":"10.1371\/journal.pone.0162373","volume":"11","author":"JX Wang","year":"2016","unstructured":"Wang JX, Zhu SL, Wang J, Lin Y, Pei YW, Sun DP, Zhang Y, et al. Seroprevalence of Enterovirus A71 and Coxsackievirus A16 in Healthy People in Shandong Province, China. PLoS One. 2016;11(9):e0162373.","journal-title":"PLoS One"},{"issue":"5","key":"688_CR23","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1038\/emi.2014.30","volume":"3","author":"X Wang","year":"2014","unstructured":"Wang X, Xing M, Zhang C, Yang Y, Chi Y, Tang X, Zhang H, Xiong S, Yu L, Zhou D. Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China. Emerg Microbes Infect. 2014;3(5):e30. https:\/\/doi.org\/10.1038\/emi.2014.30.","journal-title":"Emerg Microbes Infect"},{"issue":"12","key":"688_CR24","doi-asserted-by":"publisher","first-page":"e80515","DOI":"10.1371\/journal.pone.0080515","volume":"8","author":"W Li","year":"2013","unstructured":"Li W, Yi L, Su J, Lu J, Ke C, Zeng H, Guan D, Ma C, Zhang W, Xiao H, Li H, Lin J, Zhang Y. Seroprevalence of human enterovirus 71 and coxsackievirus A16 in Guangdong, China, in pre- and post-2010 HFMD epidemic period. PLoS One. 2013;8(12):e80515.","journal-title":"PLoS One"},{"issue":"1","key":"688_CR25","first-page":"215","volume":"7","author":"R Zhu","year":"2018","unstructured":"Zhu R, Cheng T, Yin Z, Liu D, Xu L, Li Y, Wang W, Liu J, Que Y, Ye X, Tang Q, Zhao Q, Ge S, He S, Xia N. Serological survey of neutralizing antibodies to eight major enteroviruses among healthy population. Emerg Microbes Infect. 2018;7(1):215\u201321.","journal-title":"Emerg Microbes Infect"},{"key":"688_CR26","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/1743-422X-7-300","volume":"7","author":"Z Zhu","year":"2010","unstructured":"Zhu Z, Zhu S, Guo X, Wang J, Wang D, Yan D, Tan X, Tang L, et al. Retrospective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large-scale outbreaks from 2008. Virol J. 2010;7:300. https:\/\/doi.org\/10.1186\/1743-422X-7-300.","journal-title":"Virol J"},{"issue":"7","key":"688_CR27","first-page":"573","volume":"32","author":"P Li","year":"2017","unstructured":"Li P, Chen YM, Wang HL, Wei PN. Survey of neutralizing antibodies against EV71 and Cox A16 in healthy population in Wuqing district,\u00a0Tianjin. Dis Surveillance. 2017;32(7):573\u20135.","journal-title":"Dis Surveillance"},{"issue":"2","key":"688_CR28","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4161\/hv.27087","volume":"10","author":"Q Mao","year":"2014","unstructured":"Mao Q, Wang Y, Yao X, Bian L, Wu X, Xu M, Liang Z. Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum Vaccin Immunother. 2014;10(2):360\u20137.","journal-title":"Hum Vaccin Immunother"}],"container-title":["Archives of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-021-00688-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13690-021-00688-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-021-00688-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T04:03:45Z","timestamp":1631851425000},"score":1,"resource":{"primary":{"URL":"https:\/\/archpublichealth.biomedcentral.com\/articles\/10.1186\/s13690-021-00688-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["688"],"URL":"https:\/\/doi.org\/10.1186\/s13690-021-00688-z","relation":{},"ISSN":["2049-3258"],"issn-type":[{"value":"2049-3258","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,17]]},"assertion":[{"value":"27 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}